Cargando…
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
SIMPLE SUMMARY: Immunotherapy using immune checkpoint inhibitors (ICIs) (e.g., programmed cell death protein-1 (PD-1) inhibitors) combined with molecular targeted agents has been evaluated in clinical trials and has shown potential synergic effects and superior efficacy in unresectable hepatocellula...
Autores principales: | Chiang, Hsueh-Chien, Lee, Yang-Cheng, Chang, Ting-Tsung, Lin, Yih-Jyh, Wu, Hung-Tsung, Wang, Chung-Teng, Chen, Chiung-Yu, Chen, Po-Jun, Hsieh, Ming-Tsung, Lin, Sheng-Hsiang, Chen, Shang-Hung, Chuang, Chiao-Hsiung, Wu, I-Chin, Hong, Tzu-Chun, Wu, Juei-Seng, Han, Meng-Zhi, Chen, Wei-Ting, Chiang, Chien-Ming, Hung, Kuan-Kai, Kuo, Hsin-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913272/ https://www.ncbi.nlm.nih.gov/pubmed/36765812 http://dx.doi.org/10.3390/cancers15030854 |
Ejemplares similares
-
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
por: Kuo, Hsin-Yu, et al.
Publicado: (2022) -
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
por: Wu, Juei-Seng, et al.
Publicado: (2023) -
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021) -
Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021) -
Incomplete small bowel obstruction in a patient with ankylosing spondylitis
por: Chiang, Hsueh-Chien, et al.
Publicado: (2021)